0001209191-23-058994.txt : 20231218 0001209191-23-058994.hdr.sgml : 20231218 20231218171506 ACCESSION NUMBER: 0001209191-23-058994 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silverman Peter B. CENTRAL INDEX KEY: 0001790314 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 231494709 MAIL ADDRESS: STREET 1: C/O MERUS N.V. STREET 2: YALELAAN 62 CITY: UTRECHT STATE: P7 ZIP: 3584 CM ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-15 0 0001651311 Merus N.V. MRUS 0001790314 Silverman Peter B. C/O MERUS N.V. UPPSALALAAN 17 UTRECHT P7 3584 CT NETHERLANDS 0 1 0 0 COO & GC 0 Common Shares 2023-12-15 4 M 0 21100 A 21100 D Common Shares 2023-12-15 4 M 0 1286 A 22386 D Common Shares 2023-12-15 4 S 0 22386 25.00 D 0 D Share Option (right to buy) 11.16 2023-12-15 4 M 0 21100 0.00 D 2029-02-20 Common Shares 21100 0 D Share Option (right to buy) 12.37 2023-12-15 4 M 0 1286 0.00 D 2030-04-16 Common Shares 1286 0 D Represents the exercise price of the options originally granted on February 20, 2019. Represents the exercise price of the options originally granted on April 16, 2020. Amount represents the weighted average price of shares sold, which ranged from $25.02 to $25.00. Details of individual transactions are available upon request. Options vest over a four-year period commencing February 20, 2019. 25% vest after one year and in 36 equal monthly installments thereafter. Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on February 20, 2019. Options vest over a four-year period commencing April 16, 2020. 25% vest after one year and in 36 equal monthly installments thereafter. Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on April 20, 2020. /s/ Peter Silverman as attorney-in-fact 2023-12-18